RhumbLine Advisers’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$284K Buy
+231,049
New +$284K ﹤0.01% 3017
2024
Q3
Sell
-2,834
Closed -$2.55K 4252
2024
Q2
$2.55K Sell
2,834
-570
-17% -$513 ﹤0.01% 4164
2024
Q1
$4.02K Hold
3,404
﹤0.01% 4007
2023
Q4
$3.11K Hold
3,404
﹤0.01% 4048
2023
Q3
$2.83K Sell
3,404
-4,405
-56% -$3.67K ﹤0.01% 4070
2023
Q2
$9.37K Sell
7,809
-77,552
-91% -$93.1K ﹤0.01% 3967
2023
Q1
$108K Buy
85,361
+1,344
+2% +$1.7K ﹤0.01% 2845
2022
Q4
$182K Buy
84,017
+2,084
+3% +$4.51K ﹤0.01% 2815
2022
Q3
$982K Buy
81,933
+8,283
+11% +$99.3K ﹤0.01% 2138
2022
Q2
$616K Sell
73,650
-11,310
-13% -$94.6K ﹤0.01% 2384
2022
Q1
$737K Sell
84,960
-6,304
-7% -$54.7K ﹤0.01% 2256
2021
Q4
$1.03M Buy
91,264
+717
+0.8% +$8.11K ﹤0.01% 2190
2021
Q3
$1.14M Buy
90,547
+3,223
+4% +$40.5K ﹤0.01% 2165
2021
Q2
$709K Buy
87,324
+9,056
+12% +$73.5K ﹤0.01% 2406
2021
Q1
$724K Sell
78,268
-4,040
-5% -$37.4K ﹤0.01% 2325
2020
Q4
$796K Buy
82,308
+10,008
+14% +$96.8K ﹤0.01% 2248
2020
Q3
$897K Sell
72,300
-5,795
-7% -$71.9K ﹤0.01% 2036
2020
Q2
$1.02M Buy
78,095
+17,786
+29% +$231K ﹤0.01% 2037
2020
Q1
$612K Buy
60,309
+3,030
+5% +$30.7K ﹤0.01% 2085
2019
Q4
$895K Buy
57,279
+2,266
+4% +$35.4K ﹤0.01% 2134
2019
Q3
$924K Buy
55,013
+31,453
+134% +$528K ﹤0.01% 2066
2019
Q2
$523K Buy
23,560
+11,046
+88% +$245K ﹤0.01% 2345
2019
Q1
$271K Buy
+12,514
New +$271K ﹤0.01% 2598